IL-6 circulating levels have been systematically reported to be augmented in obesity, being visceral fat secretion an important source of IL-6 thus linking the enlarged visceral fat with the existence of systemic inflammation in obese patients (Fontana et al., 2007). This evidence concerns the gene IL6 and obesity disorder.